Fmoc,Me-AMCHC
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc,Me-AMCHC

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Cyclic Amino Acids
Catalog number
BAT-005256
CAS number
173690-50-1
Molecular Formula
C24H27NO4
Molecular Weight
393.48
Fmoc,Me-AMCHC
IUPAC Name
4-[[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]methyl]cyclohexane-1-carboxylic acid
Synonyms
trans-4-(9-Fluorenylmethyloxycarbonylmethylaminomethyl)-cyclohexanoic acid; 4-[[[2-(9H-fluoren-9-ylmethoxy)-2-oxoethyl]amino]methyl]cyclohexane-1-carboxylic acid; Fmoc-N-methyl-tranexamic acid; trans-4-(Fmoc-methylaminomethyl)cyclohexane carboxylic acid
Appearance
White powder
Purity
≥ 98.5% (HPLC)
Storage
Store at 2-8 °C
InChI
InChI=1S/C24H27NO4/c1-25(14-16-10-12-17(13-11-16)23(26)27)24(28)29-15-22-20-8-4-2-6-18(20)19-7-3-5-9-21(19)22/h2-9,16-17,22H,10-15H2,1H3,(H,26,27)
InChI Key
RUPNBZQCCALWQZ-UHFFFAOYSA-N
Canonical SMILES
CN(CC1CCC(CC1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
1. Advances in Fmoc solid-phase peptide synthesis
Raymond Behrendt, Peter White, John Offer J Pept Sci. 2016 Jan;22(1):4-27. doi: 10.1002/psc.2836.
Today, Fmoc SPPS is the method of choice for peptide synthesis. Very-high-quality Fmoc building blocks are available at low cost because of the economies of scale arising from current multiton production of therapeutic peptides by Fmoc SPPS. Many modified derivatives are commercially available as Fmoc building blocks, making synthetic access to a broad range of peptide derivatives straightforward. The number of synthetic peptides entering clinical trials has grown continuously over the last decade, and recent advances in the Fmoc SPPS technology are a response to the growing demand from medicinal chemistry and pharmacology. Improvements are being continually reported for peptide quality, synthesis time and novel synthetic targets. Topical peptide research has contributed to a continuous improvement and expansion of Fmoc SPPS applications.
2. Antibacterial hydrogels of aromatic tripeptides
Vivek Prakash, Yvonne Christian, Amay Sanjay Redkar, Abhishek Roy, R Anandalakshmi, Vibin Ramakrishnan Soft Matter. 2022 Aug 31;18(34):6360-6371. doi: 10.1039/d2sm00606e.
Self-assembled peptide hydrogels have emerged as alternatives to the conventional approaches employed in controlled drug release, wound-healing, and drug delivery, and as anti-infective agents. However, peptide hydrogels possessing antibacterial properties are less explored. In this work, we have designed three ultrashort antibacterial peptide hydrogels: Fmoc-FFH-CONH2, Fmoc-FHF-CONH2, and Fmoc-HFF-CONH2. The rheological study showed the higher storage modulus of Fmoc-FFH-CONH2 (30.43 kPa) compared to Fmoc-FHF-CONH2 and Fmoc-HFF-CONH2, which may be attributed to the enhanced aromatic interaction in Fmoc-FFH-CONH2 compared to the other two variants, resulting in more mechanical rigidity. Further, the prepared hydrogels were evaluated for their inherent antibacterial potency against Gram-positive (Staphylococcus aureus, strain MTCC 96) and Gram-negative (Pseudomonas aeruginosa, strain PA01) bacteria. Antibacterial experiments demonstrated the potency of the hydrogels in the order of Fmoc-FFH-CONH2 > Fmoc-FHF-CONH2 > Fmoc-HFF-CONH2. The antibacterial effect of the hydrogels was predominantly due to the osmotic stress and membrane disruption, which was verified by reactive oxygen species (ROS) generation and outer membrane permeabilization assays. Our findings point to the scope of using the synthesized peptide hydrogels as agents for topical applications.
3. Differently N-Capped Analogues of Fmoc-FF
Carlo Diaferia, Elisabetta Rosa, Enrico Gallo, Giancarlo Morelli, Antonella Accardo Chemistry. 2023 Mar 6;e202300661. doi: 10.1002/chem.202300661. Online ahead of print.
Short and ultra-short peptides have been recently envisioned as excellent building blocks for the formulation of hydrogels with appealing properties. Due to its simplicity and capability to gel under physiological conditions, Fmoc-FF (Nα-fluorenylmethoxycarbonyl-diphenylalanine), remains one of the most studied low molecular-weight hydrogelators. Since its first identification in 2006, a plethora of its analogues were synthetized and investigated for the fabrication of novel supramolecular materials. Here we report a description of the Fmoc-FF analogues in which the aromatic Fmoc group is replaced with other substituents. These analogues are distinguished into five different classes including derivatives: i) customized with solid phase peptide synthesis protecting groups; ii) containing non-aromatic groups, iii) containing aromatic groups, iv) derivatized with metal complexes and v) containing stimuli-responsive groups. The morphological, mechanical, and functional effects caused by this modification on the resulting material are also pointed out.
Online Inquiry
Verification code
Inquiry Basket